Use of omic technologies in early life gastrointestinal health and disease: from bench to bedside

References

• Valdes AM, Walter J, Segal E, et al. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179.
   PubMedGoogle Scholar
• Zhernakova DV, Le TH, Kurilshikov A, et al. Individual variations in cardiovascular-disease-related protein levels are driven by genetics and gut microbiome. Nat Genet. 2018;50(11):1524–1532.
   PubMed Web of Science ®Google Scholar
• Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med. 2019;216(1):20–40.
   PubMed Web of Science ®Google Scholar
• Kazemian N, Mahmoudi M, Halperin F, et al. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome. 2020;8(1):36.
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330–339.
   PubMed Web of Science ®Google Scholar
• Berrington JE, Stewart CJ, Embleton ND, et al. Gut microbiota in preterm infants: assessment and relevance to health and disease. Arch Dis Child Fetal Neonatal Ed. 2013;98(4):F286–F290.
   PubMed Web of Science ®Google Scholar
• Houghteling PD, Walker WA. Why is initial bacterial colonization of the intestine important to infants’ and children’s health? J Pediatr Gastroenterol Nutr. 2015;60(3):294–307.
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Ajami NJ, O’Brien JL, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562(7728):583–588.
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17(6):852.
   PubMed Web of Science ®Google Scholar
• Gómez-Sanchiz M, Cañete R, Rodero I, et al. Influence of breast-feeding and parental intelligence on cognitive development in the 24-month-old child. Clin Pediatr (Phila). 2004;43(8):753–761.
   PubMed Web of Science ®Google Scholar
• Martinez I, Maldonado-Gomez MX, Gomes-Neto JC, et al. Experimental evaluation of the importance of colonization history in early-life gut microbiota assembly. Elife. 2018;7:e36521.
   PubMed Web of Science ®Google Scholar
• Rautava S. Early microbial contact, the breast milk microbiome and child health. J Dev Orig Health Dis. 2016;7(1):5–14.
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Embleton ND, Marrs EC, et al. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome. 2016;4(1):67.
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Nelson A, Treumann A, et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis. Pediatr Res. 2016;79(3):425–431.
   PubMed Web of Science ®Google Scholar
• Ma F, Li S, Gao X, et al. Interleukin-6-mediated CCR9+ interleukin-17-producing regulatory T cells polarization increases the severity of necrotizing enterocolitis. EBioMedicine. 2019;44:71–85.
   PubMed Web of Science ®Google Scholar
• Levy M, Thaiss CA, Elinav E. Metabolites: messengers between the microbiota and the immune system. Genes Dev. 2016;30(14):1589–1597.
   PubMed Web of Science ®Google Scholar
• Pinu FR, Beale DJ, Paten AM, et al. Systems biology and multi-omics integration: viewpoints from the metabolomics research community. Metabolites. 2019;9(4):76.
   PubMed Web of Science ®Google Scholar
• Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nat Rev Genet. 2018;19(5):299–310.
   PubMed Web of Science ®Google Scholar
• Knight R, Vrbanac A, Taylor BC, et al., Best practices for analysing microbiomes. Nat Rev Microbiol. 16(7): 410–422. 2018.
   PubMed Web of Science ®Google Scholar
• Douglas GM, Hansen R, Jones CMA, et al. Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease. Microbiome. 2018;6(1):13.
   PubMedGoogle Scholar
• Filimoniuk A, Daniluk U, Samczuk P, et al. Metabolomic profiling in children with inflammatory bowel disease. Adv Med Sci. 2020;65(1):65–70.
   PubMed Web of Science ®Google Scholar
• Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of inflammatory bowel disease: a step towards personalized medicine. J Transl Med. 2019;17(1):419.
   PubMed Web of Science ®Google Scholar
• Sylvester KG, Ling XB, Liu GY-G, et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr. 2014;164(3):607–12.e127.
   PubMed Web of Science ®Google Scholar
• Malla MA, Dubey A, Kumar A, et al. Exploring the human microbiome: the potential future role of next-generation sequencing in disease diagnosis and treatment. Front Immunol. 2019;9:2868.
   PubMed Web of Science ®Google Scholar
• Bardanzellu F, Fanos V. How could metabolomics change pediatric health? Ital J Pediatr. 2020;46(1):37.
   PubMed Web of Science ®Google Scholar
• Tang -Z-Z, Chen G, Hong Q, et al. Multi-omic analysis of the microbiome and metabolome in healthy subjects reveals microbiome-dependent relationships between diet and metabolites. Front Genet. 2019;10:454.
   PubMed Web of Science ®Google Scholar
• Kozel TR, Burnham-Marusich AR. Point-of-care testing for infectious diseases: past, present, and future. J Clin Microbiol. 2017;55(8):2313–2320.
   PubMed Web of Science ®Google Scholar
• Embleton ND, Berrington JE, Dorling J, et al. Mechanisms affecting the gut of preterm infants in enteral feeding trials. Front Nutr. 2017;4:14.
   PubMed Web of Science ®Google Scholar
• Haas R, Zelezniak A, Iacovacci J, et al. Designing and interpreting ‘multi-omic’ experiments that may change our understanding of biology. Curr Opin Syst Biol. 2017;6:37–45.
   PubMedGoogle Scholar
• D’Adamo GL, Widdop JT, Giles EM. The future is now? Clinical and translational aspects of “omics” technologies. Immunol Cell Biol. 2021;99(2):168–176.
   PubMed Web of Science ®Google Scholar
• Corlan AD. Medline trend: Automated yearly statistics of PubMed results for any query, 2004. Accessed 2021-04-27 http://dan.corlan.net/medline-trend.html
   Google Scholar
• Quince C, Walker AW, Simpson JT, et al., Shotgun metagenomics, from sampling to analysis. Nat Biotechnol. 35(9): 833–844. 2017.
   PubMed Web of Science ®Google Scholar
• Vujkovic-Cvijin I, Sklar J, Jiang L, et al. Host variables confound gut microbiota studies of human disease. Nature. 2020;587(7834):448–454.
   PubMed Web of Science ®Google Scholar
• Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18(1):83.
   PubMed Web of Science ®Google Scholar
• Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet. 2010;11(6):415–425.
   PubMed Web of Science ®Google Scholar
• Liu H-Y, Zhou L, Zheng M-Y, et al. Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases. Sci Rep. 2019;9(1):19365.
   PubMedGoogle Scholar
• Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet. 2010;42(1):30–35.
   PubMed Web of Science ®Google Scholar
• Gupta S, Mortensen MS, Schjørring S, et al. Amplicon sequencing provides more accurate microbiome information in healthy children compared to culturing. Commun Biol. 2019;2(1):291.
   PubMedGoogle Scholar
• Walker AW, Duncan SH, Louis P, et al. Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol. 2014;22(5):267–274.
   PubMed Web of Science ®Google Scholar
• Casamassimi A, Federico A, Rienzo M, et al. Transcriptome profiling in human diseases: new advances and perspectives. Int J Mol Sci. 2017;18(8):1652.
   Web of Science ®Google Scholar
• Manzoni C, Kia DA, Vandrovcova J, et al. Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform. 2018;19(2):286–302.
   PubMed Web of Science ®Google Scholar
• Aguiar-Pulido V, Huang W, Suarez-Ulloa V, et al. Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis. Evol Bioinform Online. 2016;12(Suppl 1):5–16.
   PubMedGoogle Scholar
• Shakya M, Lo CC, Chain PSG. Advances and challenges in metatranscriptomic analysis. Front Genet. 2019;10:904.
   PubMed Web of Science ®Google Scholar
• Hwang B, Lee JH, Bang D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med. 2018;50(8):96.
   PubMedGoogle Scholar
• Method of the Year 2019: single-cell multimodal omics. Nat Methods. 2020;17(1):1. https://www.nature.com/articles/s41592-019-0703-5
   PubMed Web of Science ®Google Scholar
• Marx V. Method of the year: spatially resolved transcriptomics. Nat Methods. 2021;18(1):9–14.
   PubMed Web of Science ®Google Scholar
• Altelaar AFM, Munoz J, Heck AJR. Next-generation proteomics: towards an integrative view of proteome dynamics. Nat Rev Genet. 2013;14(1):35–48.
   PubMed Web of Science ®Google Scholar
• Timp W, Timp G. Beyond mass spectrometry, the next step in proteomics. Sci Adv. 2020;6(2):eaax8978.
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Chaparro M. Clinical usefulness of proteomics in inflammatory bowel disease: a comprehensive review. J Crohns Colitis. 2018;13(3):374–384.
   Web of Science ®Google Scholar
• Aslam B, Basit M, Nisar MA, et al. Proteomics: technologies and their applications. J Chromatogr Sci. 2017;55(2):182–196.
   PubMed Web of Science ®Google Scholar
• Magdeldin S, Enany S, Yoshida Y, et al. Basics and recent advances of two dimensional- polyacrylamide gel electrophoresis. Clin Proteom. 2014;11(1):16.
   PubMedGoogle Scholar
• Issa Isaac N, Philippe D, Nicholas A, et al. Metaproteomics of the human gut microbiota: challenges and contributions to other OMICS. Clin Mass Spectrom. 2019;14:18–30.
   Google Scholar
• Vernocchi P, Del Chierico F, Putignani L. Gut microbiota profiling: metabolomics based approach to unravel compounds affecting human health. Front Microbiol. 2016;7:1144.
   PubMed Web of Science ®Google Scholar
• Contrepois K, Jiang L, Snyder M. Optimized analytical procedures for the untargeted metabolomic profiling of human urine and plasma by combining hydrophilic interaction (HILIC) and reverse-phase liquid chromatography (RPLC)-mass spectrometry. Mol Cell Proteomics. 2015;14(6):1684–1695.
   PubMed Web of Science ®Google Scholar
• Emwas AH, Roy R, McKay RT, et al. NMR spectroscopy for metabolomics research. Metabolites. 2019;9(7):123.
   PubMed Web of Science ®Google Scholar
• Del Chierico F, Nobili V, Vernocchi P, et al. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology. 2017;65(2):451–464.
   PubMed Web of Science ®Google Scholar
• Mirza AH, Berthelsen CH, Seemann SE, et al. Transcriptomic landscape of lncRNAs in inflammatory bowel disease. Genome Med. 2015;7(1):39.
   PubMedGoogle Scholar
• Berrington JE, Hearn RI, Bythell M, et al. Deaths in preterm infants: changing pathology over 2 decades. J Pediatr. 2012;160(1):49–53.e1.
   PubMed Web of Science ®Google Scholar
• Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255–264.
   PubMed Web of Science ®Google Scholar
• Allin BSR, Long A-M, Gupta A, et al. One-year outcomes following surgery for necrotising enterocolitis: a UK-wide cohort study. Arch Dis Child Fetal Neonatal Ed. 2018;103(5):F461–F466.
   PubMed Web of Science ®Google Scholar
• Hackam DJ, Sodhi CP, Good M. New insights into necrotizing enterocolitis: from laboratory observation to personalized prevention and treatment. J Pediatr Surg. 2019;54(3):398–404.
   PubMed Web of Science ®Google Scholar
• Masi AC, Stewart CJ. The role of the preterm intestinal microbiome in sepsis and necrotising enterocolitis. Early Hum Dev. 2019;138:104854.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hoenig JD, Malin KJ, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. Isme J. 2009;3(8):944–954.
   PubMed Web of Science ®Google Scholar
• Warner BB, Deych E, Zhou Y, et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet. 2016;387(10031):1928–1936.
   PubMed Web of Science ®Google Scholar
• Morrow AL, Lagomarcino AJ, Schibler KR, et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome. 2013;1(1):13.
   PubMedGoogle Scholar
• Stewart CJ, Embleton ND, Marrs ECL, et al. Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls. Microbiome. 2017;5(1):75.
   PubMedGoogle Scholar
• Shaw AG, Sim K, Randell P, et al. Late-onset bloodstream infection and perturbed maturation of the gastrointestinal microbiota in premature infants. PLoS One. 2015;10(7):e0132923.
   PubMed Web of Science ®Google Scholar
• Mai V, Torrazza RM, Ukhanova M, et al. Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLoS One. 2013;8(1):e52876.
   PubMed Web of Science ®Google Scholar
• Taft DH, Ambalavanan N, Schibler KR, et al. Center variation in intestinal microbiota prior to late-onset sepsis in preterm infants. PLoS One. 2015;10(6):e0130604.
   PubMed Web of Science ®Google Scholar
• Smith B, Bode S, Petersen BL, et al. Community analysis of bacteria colonizing intestinal tissue of neonates with necrotizing enterocolitis. BMC Microbiol. 2011;11(1):73.
   PubMedGoogle Scholar
• Stewart CJ, Fatemizadeh R, Parsons P, et al. Using formalin fixed paraffin embedded tissue to characterize the preterm gut microbiota in necrotising enterocolitis and spontaneous isolated perforation using marginal and diseased tissue. BMC Microbiol. 2019;19(1):52.
   PubMedGoogle Scholar
• Sim K, Shaw AG, Randell P, et al. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin Infect Dis. 2015;60(3):389–397.
   PubMed Web of Science ®Google Scholar
• Olm MR, Bhattacharya N, Crits-Christoph A, et al., Necrotizing enterocolitis is preceded by increased gut bacterial replication, Klebsiella, and fimbriae-encoding bacteria. Sci Adv. 5(12): eaax5727. 2019.
   PubMed Web of Science ®Google Scholar
• Wandro S, Osborne S, Enriquez C, et al. The microbiome and metabolome of preterm infant stool are personalized and not driven by health outcomes, including necrotizing enterocolitis and late-onset sepsis. mSphere. 2018;3(3). DOI:10.1128/mSphere.00104-18.
   PubMed Web of Science ®Google Scholar
• Thomaidou A, Chatziioannou AC, Deda O, et al. A pilot case-control study of urine metabolomics in preterm neonates with necrotizing enterocolitis. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1117:10–21.
   PubMed Web of Science ®Google Scholar
• Wilcock A, Begley P, Stevens A, et al. The metabolomics of necrotising enterocolitis in preterm babies: an exploratory study. J Matern Fetal Neonatal Med. 2016;29(5):758–762.
   PubMed Web of Science ®Google Scholar
• Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest. 2010;120(8):2989–3000.
   PubMed Web of Science ®Google Scholar
• Chatziioannou AC, Wolters JC, Sarafidis K, et al. Targeted LC-MS/MS for the evaluation of proteomics biomarkers in the blood of neonates with necrotizing enterocolitis and late-onset sepsis. Anal Bioanal Chem. 2018;410(27):7163–7175.
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Schelonka RL, Dimmitt RA, et al. Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatr Res. 2014;76(1):100–108.
   PubMed Web of Science ®Google Scholar
• Pang Y, Du X, Xu X, et al. Impairment of regulatory T cells in patients with neonatal necrotizing enterocolitis. Int Immunopharmacol. 2018;63:19–25.
   PubMed Web of Science ®Google Scholar
• Weitkamp J-H, Koyama T, Rock MT, et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut. 2013;62(1):73–82.
   PubMed Web of Science ®Google Scholar
• Chan KY, Leung KT, Tam YH, et al. Genome-wide expression profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in human intestinal tissues: dysregulation of functional pathways. Ann Surg. 2014;260(6):1128–1137.
   PubMed Web of Science ®Google Scholar
• Tremblay É, Thibault M-P, Ferretti E, et al. Gene expression profiling in necrotizing enterocolitis reveals pathways common to those reported in Crohn’s disease. BMC Med Genomics. 2016;9(1):6.
   PubMedGoogle Scholar
• Tremblay É, Ferretti E, Babakissa C, et al. IL-17-related signature genes linked to human necrotizing enterocolitis. BMC Res Notes. 2021;14(1):82.
   PubMed Web of Science ®Google Scholar
• Granger CL, Embleton ND, Palmer JM, et al. Maternal breastmilk, infant gut microbiome and the impact on preterm infant health. Acta Paediatr. 2021;110(2):450–457.
   PubMed Web of Science ®Google Scholar
• Autran CA, Kellman BP, Kim JH, et al. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut. 2018;67(6):1064–1070.
   PubMed Web of Science ®Google Scholar
• Masi AC, Embleton ND, Lamb CA, et al. Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis. Gut. 2020:gutjnl-2020-322771. DOI:10.1136/gutjnl-2020-322771.
   Web of Science ®Google Scholar
• Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease. J Allergy Clin Immunol. 2020;145(1):16–27.
   PubMed Web of Science ®Google Scholar
• Cococcioni L, Panelli S, Varotto-Boccazzi I, et al. IBDs and the pediatric age: their peculiarities and the involvement of the microbiota. Dig Liver Dis. 2021;53(1):17–25.
   PubMedGoogle Scholar
• Haberman Y, Karns R, Dexheimer PJ, et al., Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun. 10(1): 38. 2019.
   PubMedGoogle Scholar
• Hansen R, Russell RK, Reiff C, et al. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn’s but not in ulcerative colitis. Am J Gastroenterol. 2012;107(12):1913–1922.
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson Lee A, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15(3):382–392.
   PubMed Web of Science ®Google Scholar
• Mottawea W, Chiang C-K, Mühlbauer M, et al. Altered intestinal microbiota–host mitochondria crosstalk in new onset Crohn’s disease. Nat Commun. 2016;7(1):13419.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease. Cell Host Microbe. 2015;18(4):489–500.
   PubMed Web of Science ®Google Scholar
• Jacobs JP, Goudarzi M, Singh N, et al. A disease-associated microbial and metabolomics state in relatives of pediatric inflammatory bowel disease patients. Cell Mol Gastroenterol Hepatol. 2016;2(6):750–766.
   PubMed Web of Science ®Google Scholar
• Chehoud C, Albenberg LG, Judge C, et al. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1948–1956.
   PubMed Web of Science ®Google Scholar
• Assa A, Butcher J, Li J, et al. Mucosa-associated ileal microbiota in new-onset pediatric Crohn’s disease. Inflamm Bowel Dis. 2016;22(7):1533–1539.
   PubMed Web of Science ®Google Scholar
• Zhang X, Deeke SA, Ning Z, et al. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun. 2018;9(1):2873.
   PubMed Web of Science ®Google Scholar
• Schirmer M, Denson L, Vlamakis H, et al. Compositional and temporal changes in the gut microbiome of pediatric ulcerative colitis patients are linked to disease course. Cell Host Microbe. 2018;24(4):600–610.e4.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao X, Zhang X, et al. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease. Gut Microbes. 2021;13(1):1–18.
   PubMed Web of Science ®Google Scholar
• Cortez RV, Moreira LN, Padilha M, et al. Gut microbiome of children and adolescents with primary sclerosing cholangitis in association with ulcerative colitis. Front Immunol. 2021;11:598152.
   PubMed Web of Science ®Google Scholar
• Kolho K-L, Pessia A, Jaakkola T, et al. Faecal and serum metabolomics in paediatric inflammatory bowel disease. J Crohns Colitis. 2016;11(3):321–334.
   Web of Science ®Google Scholar
• Martin F-P, Ezri J, Cominetti O, et al. Urinary metabolic phenotyping reveals differences in the metabolic status of healthy and inflammatory bowel disease (IBD) children in relation to growth and disease activity. Int J Mol Sci. 2016;17(8):1310.
   Web of Science ®Google Scholar
• Martin F-P, Su -M-M, Xie G-X, et al. Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children. World J Gastroenterol. 2017;23(20):3643–3654.
   PubMed Web of Science ®Google Scholar
• Deeke SA, Starr AE, Ning Z, et al. Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis. Am J Gastroenterol. 2018;113(5):713–724.
   PubMed Web of Science ®Google Scholar
• Starr AE, Deeke SA, Ning Z, et al. Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn’s disease from UC. Gut. 2017;66(9):1573–1583.
   PubMed Web of Science ®Google Scholar
• Haberman Y, Tickle TL, Dexheimer PJ, et al., Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 124(8): 3617–3633. 2014.
   PubMed Web of Science ®Google Scholar
• Ta AD, Ollberding NJ, Karns R, et al. Association of baseline luminal narrowing with ileal microbial shifts and gene expression programs and subsequent transmural healing in pediatric Crohn disease. Inflamm Bowel Dis. 2021;16:izaa339.
   Google Scholar
• Griffin BH, Chitty LS, Bitner-Glindzicz M. The 100 000 genomes project: what it means for paediatrics. Arch Dis Child Educ Pract Ed. 2017;102(2):105–107.
   PubMed Web of Science ®Google Scholar
• Casals-Pascual C, González A, Vázquez-Baeza Y, et al. Microbial diversity in clinical microbiome studies: sample size and statistical power considerations. Gastroenterology. 2020;158(6):1524–1528.
   PubMed Web of Science ®Google Scholar